sepsis
HIMSS25
Darren Webber and Nathan Licht, principal data analysts at Cedars-Sinai, preview their HIMSS25 talk on how generative AI can enhance chart abstractors’ efficiency and effectiveness, as well as best practices for implementation.
This marks AITRICS's first foray into Southeast Asia, with applications for regulatory clearance in Indonesia and Malaysia underway.
The company will use the funds to expand the reach of its sepsis-focused diagnostic test, IntelliSep.
Also, Syntekabio has launched its cloud service platform for AI drug discovery.
The technology uses heart rate variability measurements to assess the severity of sepsis in ED patients.
The UK Sepsis Trust said that while there was “no perfect test for sepsis”, the study “serves to remind us that technology is advancing ever closer to providing the answers”.
Ambient Clinical Analytics, a remote patient monitoring company that spun off from Mayo Clinic in 2013, has raised $1.